InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Yeramian Patrick D, Directeur Médical. Officer active across 1 companies, notably Amylyx Pharmaceuticals, Inc.. In total, 2 reports have been logged. The latest transaction was disclosed on 6 January 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
028,333 shares0
Common Stock
SEC:0000899243-22-001522·
028,333 shares0
Common Stock
SEC:0000899243-22-001522:0·
2 of 2 declarations
About Yeramian Patrick D
Patrick D. Yeramian is the Chief Medical Officer at Amylyx Pharmaceuticals, Inc. He is responsible for the company's medical and research strategies. With a strong background in the medical field, Yeramian contributes to the innovation and effectiveness of treatments developed by Amylyx.
